| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |